Found 4 matching trials
A Phase 3 Study to Evaluate the Safety and Efficacy of AOC 1044 (Also Referred to as Delpacibart Zotadirsen) in Participants With DMD With Gene Mutations Amenable to Exon 44 Skipping PHASE3 A Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate t...
Show More Learn More & Join Trial
Managed Access Program for Del-zota in Participants With DMD Mutations Amenable to Exon 44 Skipping N/A The purpose of this Managed Access Program is to allow access to delpacibar...
Show More Location
University of Alabama
Learn More & Join Trial
Ph2 Open-label Study of AOC 1044 in Duchenne Muscular Dystrophy Participants With Mutations Amenable to Exon44 Skipping PHASE2 AOC 1044-CS2 (EXPLORE44-OLE) is an Open-label Study to Evaluate the Long-Te...
Show More Status
Active Not Recruiting
Location
Arkansas Children's Hospital
Learn More & Join Trial
Study of AOC 1044 in Healthy Adult Volunteers and Participants With Duchenne Muscular Dystrophy (DMD) Mutations Amenable to Exon 44 Skipping PHASE1 AOC 1044-CS1 (EXPLORE44) is a Phase 1/2 study to evaluate the safety, toler...
Show More Location
Arkansas Children's
Learn More & Join Trial